Is there financial assistance available for Afinitor?
Novartis Pharmaceuticals Corporation is committed to providing access to our medications through a number of patient access programs. Please contact AfiniTRAC® at 1-888-5AfiniTRAC (1-888-523-4648). Please keep in mind that Afinitor has been approved for patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib and only patients with this diagnosis will be eligible. The following organizations and websites are independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for any information they may provide.
